The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms (2016)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; COVAS, DIMAS TADEU - FMRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.bcmd.2016.03.008
- Subjects: LEUCEMIA MIELOIDE; DOENÇA CRÔNICA; APOPTOSE; TROMBOCITOSE
- Keywords: Myeloproliferative Neoplasms; DIDO; Apoptosis; JAK2V617F; BCR-ABL1
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2016
- Source:
- Título do periódico: Blood Cells, Molecules, and Diseases
- ISSN: 1079-9796
- Volume/Número/Paginação/Ano: v. 59, p.25-30, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BERZOTI-COELHO, Maria Gabriela et al. The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms. Blood Cells, Molecules, and Diseases, v. 59, p. 25-30, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2016.03.008. Acesso em: 19 abr. 2024. -
APA
Berzoti-Coelho, M. G., Ferreira, A. F., Nunes, N. de S., Pinto, M. T., Rocha Júnior, M. C., Simões, B. P., et al. (2016). The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms. Blood Cells, Molecules, and Diseases, 59, 25-30. doi:10.1016/j.bcmd.2016.03.008 -
NLM
Berzoti-Coelho MG, Ferreira AF, Nunes N de S, Pinto MT, Rocha Júnior MC, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA de. The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms [Internet]. Blood Cells, Molecules, and Diseases. 2016 ; 59 25-30.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.bcmd.2016.03.008 -
Vancouver
Berzoti-Coelho MG, Ferreira AF, Nunes N de S, Pinto MT, Rocha Júnior MC, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA de. The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms [Internet]. Blood Cells, Molecules, and Diseases. 2016 ; 59 25-30.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.bcmd.2016.03.008 - ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance
- Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- PRV-1 overexpression in essential thrombocythemia correlates with trail expression
- Apoptomirs expression profile in polycythemia vera patients
- Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]
- Avaliação do perfil de resistência dos lifócitos de pacientes com trombocitemia essencial aos agentes apoptogênicos
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- Menchymal stromal cells in the treatment of grade III-IV steroid-resistant GVHD
Informações sobre o DOI: 10.1016/j.bcmd.2016.03.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
